Nodular fasciitis: A novel model of transient neoplasia induced by MYH9-USP6 gene fusion

Laboratory Investigation

Volumn 91, Issue 10, 2011, Pages 1427-1433

  Erickson Johnson, Michele R ^a   Chou, Margaret M ^b   Evers, Barbara R ^a   Roth, Christopher W ^a   Seys, Amber R ^a   Jin, Long ^a   Ye, Ying ^b   Lau, Alan W ^b   Wang, Xiaoke ^a   Oliveira, Andre M ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

MYH9; nodular fasciitis; USP6

Indexed keywords

ANIMAL TISSUE; ARTICLE; DIFFERENTIAL DIAGNOSIS; GENE; GENE FUSION; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; MYH9 GENE; NODULAR FASCIITIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOSARCOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA; USP6 GENE; XENOGRAFT;

ADOLESCENT; ADULT; AGED; ANIMALS; BASE SEQUENCE; CADHERINS; CHILD; CHILD, PRESCHOOL; COLLAGEN TYPE I; FASCIITIS; FEMALE; GENE EXPRESSION PROFILING; GENE FUSION; GENE REARRANGEMENT; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICE; MICE, NUDE; MIDDLE AGED; MOLECULAR MOTOR PROTEINS; MYOSIN HEAVY CHAINS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA; TRANSLOCATION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; UBIQUITIN THIOLESTERASE; UP-REGULATION; YOUNG ADULT;

EID: 80053349575     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.118     Document Type: Article

References (31)

1. Fletcher CDM, Unni KK, Mertens F. World Health Organization classification of tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: France, 2005.
2. Kumar V, Abbus AK, Fausto N, et al. Robbins & Cotran Pathologic Basis of Disease. In Elsevier Saunders: Philadelphia, PA, 2004; 1318.
3. Velagaleti GV, Tapper JK, Panova NE, et al. Cytogenetic findings in a case of nodular fasciitis of subclavicular region. Cancer Genet Cytogenet 2003;141:160-163. (Pubitemid 36269218)
4. Tomita S, Thompson K, Carver T, et al. Nodular fasciitis: a sarcomatous impersonator. J Pediatr Surg 2009;44:e17-e19.
5. Wagner LM, Gelfand MJ, Ryckman FC, et al. A welcome surprise: nodular fasciitis presenting as a soft tissue sarcoma. J Pediatr Hematol Oncol 2010.
6. Silvanto AM, Melly L, Hannan SA, et al. FNAC of nodular fasciitis mimicking a pleomorphic adenoma: another diagnostic pitfall. Cytopathology 2010;21:276-277.
7. Konwaler B, Keasbey L, Kaplan L. Subcutaneous pseudosarcomatous fibromatosis (fasciitis). Am J Clin Pathol 1955;25:241-252.
8. Sawyer JR, Sammartino G, Baker GF, et al. Clonal chromosome aberrations in a case of nodular fasciitis. Cancer Genet Cytogenet 1994;76:154-156. (Pubitemid 24317437)
9. Weibolt VM, Buresh CJ, Roberts CA, et al. Involvement of 3q21 in nodular fasciitis. Cancer Genet Cytogenet 1998;106:177-179. (Pubitemid 28476098)
10. Donner LR, Silva T, Dobin SM. Clonal rearrangement of 15p11.2, 16p11.2, and 16p13.3 in a case of nodular fasciitis: additional evidence favoring nodular fasciitis as a benign neoplasm and not a reactive tumefaction. Cancer Genet Cytogenet 2002;139:138-140. (Pubitemid 36110654)
11. Birdsall SH, Shipley JM, Summersgill BM, et al. Cytogenetic findings in a case of nodular fasciitis of the breast. Cancer Genet Cytogenet 1995;81:166-168.
12. Oliveira AM, Perez-Atayde AR, Inwards CY, et al. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol 2004;165:1773-1780. (Pubitemid 39435174)
13. Oliveira AM, Perez-Atayde AR, Dal Cin P, et al. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene 2005;24:3419-3426. (Pubitemid 40756243)
14. Oliveira AM, Chou MM, Perez-Atayde AR, et al. Aneurysmal bone cyst: a neoplasm driven by upregulation of the USP6 oncogene. J Clin Oncol 2006;24:e1.
15. Oliveira AM, Hsi BL, Weremowicz S, et al. USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst. Cancer Res 2004;64:1920-1923. (Pubitemid 38339434)
16. Ye Y, Pringle LM, Lau AW, et al. TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB. Oncogene 2010;29: 3619-3629.
17. Lau AW, Pringle LM, Quick L, et al. Tre17/ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation. J Biol Chem 2010;285: 37111-37120.
18. Qian X, Jin L, Shearer BM, et al. Molecular diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor in formalin-fixed paraffinembedded tissues by RT-PCR and fluorescence in situ hybridization. Diagn Mol Pathol 2005;14:23-28. (Pubitemid 40283858)
19. Erickson-Johnson MR, Seys AR, Roth CW, et al. Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma. Mod Pathol 2009;12:1541-1547.
20. Welman A, Barraclough J, Dive C. Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2. Nat Protoc 2006;1:803-811.
21. D'Apolito M, Guarnieri V, Boncristiano M, et al. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes. Gene 2005;286:215-222. (Pubitemid 34273877)
22. Wilson CA, Tsuchida MA, Allen GM, et al. Myosin II contributes to cellscale actin network treadmilling through network disassembly. Nature 2010;465:373-377.
23. Hu A, Wang F, Sellers JR. Mutations in human nonmuscle myosin IIA found in patients with May-Hegglin anomaly and Fechtner syndrome result in impaired enzymatic function. J Biol Chem 2002;277: 46512-46517. (Pubitemid 35417648)
24. Lamant L, Gascoyne RD, Duplantier M, et al. Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma. Genes Chromosomes Cancer 2003;37:427-432. (Pubitemid 36775787)
25. Landrette SF, Kuo YH, Hensen K, et al. Plag1 and Plag2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MHY11. Blood 2005;105:2900-2907. (Pubitemid 40450321)
26. Heath KE, Campos-Barros A, Toren A, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001; 69:1033-1045. (Pubitemid 33015818)
27. Shaffer LG, Tommerup N (eds). An International System for Human Cytogenetic Nomenclature (ISCN). S Karger, Basel, 2005.
28. Knezevich SR, McFadden DE, Tao W, et al. A novel ETV6-NTKR3 gene fusion in congenital fibrosarcoma. Nat Genet 1998;18: 184-187. (Pubitemid 28082471)
29. Rubin BP, Chen CJ, Morgan TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTKR3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 1998;153:1451-1458. (Pubitemid 28509901)
30. Allen PW. Nodular fasciitis. Pathology 1972;4:9-26.
31. Brassesco M. Leukemia/lymphoma-associated gene fusions in normal individuals. Genet Mol Res 2008;7:782-790.